Gulack, B.C., Nussbaum, D.P., Keenan, J.E., Ganapathi, A.M., Sun, Z.F., Worni, M., et al. (2016) Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer without Metastasectomy is Associated with Improved Overall Survival Compared to Chemotherapy/Radiation Therapy Alone. Diseases of the Colon & Rectum, 59, 299-305.
https://doi.org/10.1097/DCR.0000000000000546

has been cited by the following article:

• TITLE: Analysis of 154 T4 Colorectal Cancer Patients with Peritoneal Carcinomatosis Treated by Surgery

  AUTHORS: Wei Chen, Junwen Ye, Xiaoping Tan, Yan Zhang, Jinglin Liang, Meijin Huang

  KEYWORDS: Colorectal Cancer, Peritoneal Carcinomatosis, Surgery, Prognosis

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.12 No.2, February 24, 2021

  ABSTRACT: Objective: The purpose of this study was to observe the factors related to T4 patients who underwent surgery for colorectal cancer (CRC) with peritoneal carcinomatosis. Methods: 154 T4 colorectal cancer patients who underwent surgery in the first Affiliated Hospital of Sun Yat-sen University were included in the study between August, 1994 and December, 2005. Some clinical variables were selected and statistically correlated with prognosis. Results: The overall survival time was 91.7 months at the end of December of 2010 or death. The complete cytoreduction had significant survival benefit than the palliative surgery group. The age, location, histological grade, complete cytoreduction and liver metastasis were associated with overall survival time (OS) according to the univariate analysis (P Conclusion: Compared with palliative surgery, the incomplete cytoreduction fails to improve patient prognosis. Patients performed completed cytoreduction have a relative good prognosis.